StonvexLoading…
StonvexStonvexStonvexCore line items from HBAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-23 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.91B | $472.00M | $1.56B | $1.15B | $728.00M |
Operating Income | Not available | $641.00M | $2.69B | $2.06B | $1.29B |
Net Income | Not available | $523.00M | $2.21B | $1.69B | $1.06B |
EPS (Diluted) | $0.37 | $0.25 | $1.39 | $1.09 | $0.68 |
Total Assets | Not available | $285.37B | $225.11B | $210.23B | $207.74B |
Total Liabilities | Not available | $252.79B | $200.73B | $187.94B | $186.77B |
Cash & Equivalents | Not available | $19.19B | $13.49B | $12.74B | $10.36B |
Free Cash Flow OCF − CapEx | Not available | $400.00M | $2.21B | $1.41B | $959.00M |
Shares Outstanding | Not available | 2.03B | 1.57B | 1.46B | 1.46B |